Vecuronium: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Not recommended for RSI | *Not recommended for RSI | ||
*0. | *0.15mg/kg IV based on ideal body weight, can prime with 0.01mg/kg IV | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
Revision as of 23:30, 20 July 2016
General
- Type: Neuromuscular blocker, nondepolarizing, fast
- Dosage Forms: IV
- Common Trade Names: Norcuron
Adult Dosing
- Not recommended for RSI
- 0.15mg/kg IV based on ideal body weight, can prime with 0.01mg/kg IV
Pediatric Dosing
- Not recommended for RSI
Special Populations
- Pregnancy Rating: C
- Lactation: Infant risk cannot be ruled out
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life: Varies, from 30-60 minutes
- Metabolism: Hepatic
- Excretion: Renal
- Mechanism of Action: Non-depolarizing neuromuscular blocking agent. Long duration with slow onset. Competes for cholinergic receptors at the motor end-plate. Acetylcholinesterase inhibitors like those found in organophosphates antagonize this action
See Also
References
Micromedex